TOP STORIES — Diabetes News and Research
Deadlier Strokes in Patients with Alzheimer’s and Diabetes
Can ACE Inhibitors Lower Type 2 Diabetes Risk?
Incidence and Remission of Obesity and Abdominal Obesity with Changes in Physical Activity
MOST POPULAR ARTICLES OF THE MONTH
#1 Hemoglobin A1C levels – Indicators of Coronary Atherosclerotic Plaque
#2 MODY Testing in Patients Newly Diagnosed with Type 1 Diabetes
#3 Can Closed Loop Systems Be Effective for Type 1 Diabetes?
Letter from the Editor
Lately it seems that more and more drugs that we use to manage diabetes are proving to be very good proponents in the battle against heart disease. We all have heard the value of the SGLT-2 inhibitors in reducing cardiovascular risk, and they even carry the indication. The GLP-1 Mimetics also have research showing their value.
Now our current intern, George McConnell, PharmD. Candidate, LECOM School of Pharmacy, has found that an older drug for hypertension can actually help lower type 2 diabetes risk and interestingly enough, we advocate giving this medication to every diabetes patient, regardless if they have hypertension.
Click here to find out which medication we are talking about.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
Either condition alone may impact stroke risk, and the combination of Alzheimer’s and diabetes could be particularly devastating.
ACE inhibitors may have potential uses in diabetes, aside from lowering blood pressure.
How much of a change in physical activity is needed for patients to benefit?